High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis

BACKGROUND: Migraine and depression are highly prevalent and partly overlapping disorders that cause strong limitations in daily life. Patients tend to respond poorly to the therapies available for these diseases. OnabotulinumtoxinA has been proven to be an effective treatment for both migraine and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Affatato, Oreste, Moulin, Thiago C., Pisanu, Claudia, Babasieva, Victoria S., Russo, Marco, Aydinlar, Elif I., Torelli, Paola, Chubarev, Vladimir N., Tarasov, Vadim V., Schiöth, Helgi B., Mwinyi, Jessica
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011097/
https://ncbi.nlm.nih.gov/pubmed/33789668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02801-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars